last thursday, november 9th, right off the election, john in texas asked about greenway medical, gway. they just won a big new contract with walgreens. health care technology solution that will supply electronic medical records to 8,300 walgreens. besides being certified, 37 times next year's earnings? too expensive for this guy. i wouldn't touch it. wait for an earnings hiccup, something we've seen from these health care i.t. providers. that will give you the pullback you need before you can build a position. we have lost too much money in this market buying stocks that sell for more than 30 times earnings. now september 14th, i highlighted a speculative opportunity in a company called dynamax. at the time it looked like they had a better hepatitis vaccine and the risk profile wouldn't dissuade the fda from approving it in an upcoming panel in february. unfortunately for shareholders, the fda panel met yesterday and asked the company to present more safety data. in response on that, the stock got crushed and fell $2.19, 47%. dynavax represents the downside of speculation. this is a l